0HX

pentan-3-yl 2-acetamido-2,4-dideoxy-alpha-L-threo-hex-4-enopyranosiduronic acid

Created:	2012-01-19
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where 0HX is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	41
Chiral Atom Count	3
Bond Count	41
Aromatic Bond Count	0

2D diagram of 0HX

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	pentan-3-yl 2-acetamido-2,4-dideoxy-alpha-L-threo-hex-4-enopyranosiduronic acid
Synonyms	pentan-3-yl 2-(acetylamino)-2,4-dideoxy-alpha-L-threo-hex-4-enopyranosiduronic acid; pentan-3-yl 2-acetamido-2,4-dideoxy-alpha-L-threo-hex-4-enosiduronic acid; pentan-3-yl 2-acetamido-2,4-dideoxy-L-threo-hex-4-enosiduronic acid; pentan-3-yl 2-acetamido-2,4-dideoxy-threo-hex-4-enosiduronic acid
Systematic Name (OpenEye OEToolkits)	(2~{R},3~{R},4~{S})-3-acetamido-4-oxidanyl-2-pentan-3-yloxy-3,4-dihydro-2~{H}-pyran-6-carboxylic acid
Formula	C₁₃ H₂₁ N O₆
Molecular Weight	287.309
Type	L-SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CCC(CC)O[CH]1OC(=C[CH](O)[CH]1NC(C)=O)C(O)=O
SMILES	OpenEye OEToolkits	2.0.7	CCC(CC)OC1C(C(C=C(O1)C(=O)O)O)NC(=O)C
Canonical SMILES	CACTVS	3.385	CCC(CC)O[C@@H]1OC(=C[C@H](O)[C@H]1NC(C)=O)C(O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCC(CC)O[C@H]1[C@@H]([C@H](C=C(O1)C(=O)O)O)NC(=O)C
InChI	InChI	1.03	InChI=1S/C13H21NO6/c1-4-8(5-2)19-13-11(14-7(3)15)9(16)6-10(20-13)12(17)18/h6,8-9,11,13,16H,4-5H2,1-3H3,(H,14,15)(H,17,18)/t9-,11+,13+/m0/s1
InChIKey	InChI	1.03	UUULUCUBSUJBNQ-UFGOTCBOSA-N

Related Resource References

Resource Name	Reference
PubChem	11380651
ChEMBL	CHEMBL2170522

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.